Annick Mühlethaler-Mottet

4PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Jan 13, 2022
TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth.

Maria-Vittoria Sepporta, Viviane Praz, Katia Balmas Bourloud

|Jun 11, 2021
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).

Angela Bellini, Ulrike Pötschger, Virginie Bernard

|Oct 12, 2016
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.

Marjorie Flahaut, Nicolas Jauquier, Nadja Chevalier

Pageof 1

Frequent Collaborators

2 joint publications

Deborah A Tweddle

2 joint publications

Maja Popovic-Beck

2 joint publications

Gudrun Schleiermacher

2 joint publications

Klaus H Beiske